LifeStance Health (LFST) Change in Accured Expenses (2020 - 2026)

LifeStance Health has disclosed Change in Accured Expenses across 7 years of filings, most recently posting $9.8 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 322.48% year-over-year to $9.8 million; the TTM figure through Mar 2026 stood at $8.2 million (up 5.1% YoY), while the FY2025 annual figure was -$5.9 million, down 139.54% from the prior year.
• Change in Accured Expenses grew to $9.8 million in Q1 2026, from -$2.2 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for LFST reached as high as $17.3 million in Q2 2024 and fell as low as -$17.3 million in Q4 2022.
• The 5-year median for Change in Accured Expenses is $2.8 million (2024), against an average of $1.8 million.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 891.65% — and 2024, when it soared 442.84%.
• A 5-year view of Change in Accured Expenses shows it stood at -$17.3 million in 2022, then jumped by 114.98% to $2.6 million in 2023, then jumped by 83.83% to $4.8 million in 2024, then slumped by 147.05% to -$2.2 million in 2025, then surged by 536.4% to $9.8 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $9.8 million, -$2.2 million, and -$3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.